Skip to main content

San Francisco biopharm tech company opens regional HQ in Bethesda

Vineti closed on a $33.5 million Series B round last year, bringing its total capital raised to more than $47 million.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.